tirzepatide side effects hair loss has increasingly been reported among patients using GLP-1 and GIP agonists for weight loss. These include drugs like semaglutide, tirzepatide, liraglutide and others. Historically, this hair loss has been attributed Tirzepatide and Hair Loss: Clinical
Description
If retatrutide follows the typical regulatory pathway, a first approval for obesity could arrive in 2026 or 2027
Reduced tolerance, increased nausea after fewer drinks, and a general decrease in the desire to drink are commonly reported
[23] Pham, C.T., Romero, K., Almohanna, H.M., Griggs, J., Ahmed, A., Tosti, A
The company expects the agency could reach a decision as early as late 2023
Moreover, obesity alters the molecular structure of collagen, disrupting skin integrity and leading to reduced mechanical strength and impaired wound healing [26]
It is important to note that studies exploring the rate of T1D progression have mainly been conducted in paediatric populations [32]
